medigraphic.com
SPANISH

Revista Mexicana de Cardiología

ISSN 0188-2198 (Print)
En 2019, la Revista Mexicana de Cardiología cambió a Cardiovascular and Metabolic Science

Ver Cardiovascular and Metabolic Science


  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 1

<< Back Next >>

Rev Mex Cardiol 2007; 18 (1)

Early stratification in patients with acute myocardial infarction with elevation of the ST segment. ETIAM-ST study. First phase

Borrayo SG, Almeida GE, Benítez PC, Madrid MA, Reyes HA, Velasco LG, Sosa JF, López VLT, Guardado MM, Sánchez I, Luviano D, Aparicio HL, Vieyra G, Antezana CJ, Argüero SR
Full text How to cite this article

Language: Spanish
References: 10
Page: 17-23
PDF size: 84.12 Kb.


Key words:

Acute myocardial infarction, early stratification.

ABSTRACT

Objective: To stratify early patients with acute myocardial infarction with elevation of the ST segment (IAM-CST) in the UCIC. Material and methods: There were included patients serial of any age and gender entered the UCIC with diagnostic of acute myocardial infarction with elevation of the ST at any location, with 2 of the following approaches: a) Chest pain ≥ 20 minutes of duration, b) ST elevation ≥ 2 mm in two anterior contiguous derivations or ≥ 1 mm in two contiguous derivations of the others, c) Elevation to double the creatinphosphokinase normal value. Patients were stratified with the factors of risk, age group, gender, clinical presentation for further complications during their stay in the UCIC. Statistical analysis: The data was presented on the average and standard deviation, percentages. The differences of dichotomy variables were evaluated with χ2, the continuous variables with Student t test. The risk was evaluated with relative risk with confidence interval of 95%. The confusion variable was analyzed with logistical regression. It was considered significant a value of p ≤ 0.05, with confidence interval of 95%. Results: From January 2003 to July 2006, 2,865 patients were registered with Acute Coronary Syndrome, from those 1,925 (66.4%) had IAM-CST, the age average was 62 ± 16 years, 1,444 men (75%) and 481 women (25%). The most frequent electric complications were: blockade of right branch (BRDHH) in 11%, complete auriculoventricular blockade (BAVC) in 8.4% and blockade of left branch (BRIHH) in 6.3%. The most frequent clinical complications were: recurrent ischemia (17.5%), heart failure in 16.4%, cardiogenic shock (9.8%) and non fatal infarction (7.8%). The significant factors of risk for recurrent ischemia were: age › 65 years, female, class of Killip ≥ 2, BAVC, BRIHH, previous IAM and fibrinogen › 500 mg/dL. For non fatal infarction: age › 65 years, DM, in female, class of Killip ≥ 2, PAS 8249, 90 mmHg, BAVC, BRIHH, BRDHH, previous IAM and creatinine › 1.5 mg/dL. For flaw ventricular left: age › 65 years, DM, in female, fibrinogen › 500 mg/dL, class of Killip ≥ 2, FC › 100 lpm, PAS ‹ 90 mmHg, BAVC, BRIHH, BRDHH, previous IAM and creatinine › 1.5 mg/dL. For crash cardiogenic: age › 65 years, DMK, feminine gender, class of Killip ≥ 3, FC › 100 lpm, PAS ‹ 90 mmHg, BAVC, BRIHH, BRDHH and creatinine › 1.5 mg/dL. For death: age › 65 years, DMK, there are, tobaccoism, feminine gender, fibrinogen › 500 mg/dL, class of Killip ≥ 2, FC › 100 lpm, PAS ‹ 90 mmHg, BAVC, BRIHH, BRDHH, previous IAM and creatinine › 1.5 mg/dL. Conclusions: The early stratification in patients with IAM-CST should be stratify in the first hours of evolution, taking into account the patient’s basal characteristics as age, gender, factors of risk, followed by the electrocardiography complications like BRDHH, BRIHH, BAVC, as well as the clinical data of hypotension, tachycardia, class of advanced Killip, high level of creatinine and fibrinogen › 500 mg/dL.


REFERENCES

  1. Jacobs D, Kroenke C, Crow R et al. PREDICT: a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey. Circulation 1999; 100: 599-607.

  2. Morrow D, Antman E, Charlesworth A et al. TIMI Risk Score for ST-Elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation an intravenous nPA treatment of infarcting myocardium early II trail substudy. Circulation 2000; 102: 2031-2037.

  3. Morrow D, Antman E, Giugliano R et al. A simple risk index for rapid initial traige of patients with ST-elevation myocardial infarction: an InTIME substudy. Lancet 2001; 358: 1571-75.

  4. Steg PG, Dabbous OH, Feldman LJ et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes. Observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004; 109: 494-499.

  5. Marrugat J, Sala J, Masia J et al. Mortality differences between men and women following first myocardial infarction. JAMA 1998; 280: 1405-9.

  6. Chang W, Kaul P, Westerhow TC et al. Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. Arch Intern Med 2003; 1632476-84.

  7. Reina A, Colmenero M, Aguayo E et al. Gender differences in management and outcome of patients with acute myocardial infarction. Inter J Cardiol 2006; in press. 10. 1016.j.ijcard.2006.06.007.

  8. Bodi V, Facila L, Sanchis A et al. Pronóstico a corto plazo de los pacientes ingresados por probable síndrome coronario agudo sin elevación del segmento ST. Papel de los nuevos marcadores de daño miocárdico y de los reactantes de fase aguda. Rev Esp Cardiol 2002; 55(8): 823-30.

  9. Toss H, Lindahl B, Siegbahn A et al. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997; 96: 4204-10.

  10. Borrayo S, Madrid M, Contreras R y cols. Pronóstico de hiperfibrinogenemia en pacientes con síndrome coronario agudo. Rev Mex Cardiol 2002; 13(3): 102.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cardiol. 2007;18